Nerea Jimenez-Tellez

Dr. Nerea Jimenez-Tellez

Cardiovascular Insitute, Stanford Medicine, Stanford, California, USA
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2019 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
PDF file
PMPranav Machiraju
Pranav Machiraju
XWXuemei Wang
Xuemei Wang
RSRasha Sabouny
Rasha Sabouny
JHJoshua Huang
Joshua Huang
TZTian Zhao
Tian Zhao
SGSteven Greenway
Steven Greenway
We used patient dermal fibroblasts to characterize the mitochondrial abnormalities associated with the dilated cardiomyopathy with ataxia syndrome (DCMA) and to study the effect of the mitochondrially-targeted peptide SS-31 as a potential novel therapeutic. DCMA is a rare and understudied autosomal recessive disorder thought to be related to Barth syndrome but caused by mutations in DNAJC19, a protein of unknown function localized to the mitochondria. The clinical disease is characterized by 3-methylglutaconic aciduria, dilated cardiomyopathy, abnormal neurological development, and other heterogeneous features. Until recently no effective therapies had been identified and affected patients frequently died in early childhood from intractable heart failure. Skin fibroblasts from four pediatric patients with DCMA were used to establish parameters of mitochondrial dysfunction. Mitochondrial structure, reactive oxygen species (ROS) production, cardiolipin composition, and gene expression were evaluated. Immunocytochemistry with semi-automated quantification of mitochondrial structural metrics and transmission electron microscopy demonstrated mitochondria to be highly fragmented in DCMA fibroblasts compared to healthy control cells. Live-cell imaging demonstrated significantly increased ROS production in patient cells. These abnormalities were reversed by treating DCMA fibroblasts with SS-31, a synthetic peptide that localizes to the inner mitochondrial membrane. Levels of cardiolipin were not significantly different between control and DCMA cells and were unaffected by SS-31 treatment. Our results demonstrate the abnormal mitochondria in fibroblasts from patients with DCMA and suggest that SS-31 may represent a potential therapy for this devastating disease.

26 October 2019 in World Journal of Cardiology
Verified
Journal Article
Open access
Nerea Jimenez-TellezNerea Jimenez-Tellez
Nerea Jimenez-Tellez
SGSteven Greenway
Steven Greenway
Cellular models for human cardiomyopathy: What is the best option?

9 August 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Nerea Jimenez-TellezNerea Jimenez-Tellez
Nerea Jimenez-Tellez
FIFahad Iqbal
Fahad Iqbal
MPMarcus Pehar
Marcus Pehar
ACAlberto Casas-Ortiz
Alberto Casas-Ortiz
TRTiffany Rice
Tiffany Rice
Naweed SyedNaweed Syed
Naweed Syed
Recent animal studies have drawn concerns regarding most commonly used anesthetics and their long-term cytotoxic effects, specifically on the nervous tissue. It is therefore imperative that the search continues for agents that are non-toxic at both the cellular and behavioural level. One such agent appears to be dexmedetomidine (DEX) which has not only been found to be less neurotoxic but has also been shown to protect neurons from cytotoxicity induced by other anesthetic agents. However, DEX’s effects on the growth and synaptic connectivity at the individual neuronal level, and the underlying mechanisms have not yet been fully resolved. Here, we tested DEX for its impact on neuronal growth, synapse formation (in vitro) and learning and memory in a rodent model. Rat cortical neurons were exposed to a range of clinically relevant DEX concentrations (0.05–10 µM) and cellular viability, neurite outgrowth, synaptic assembly and mitochondrial morphology were assessed. We discovered that DEX did not affect neuronal viability when used below 10 µM, whereas significant cell death was noted at higher concentrations. Interestingly, in the presence of DEX, neurons exhibited more neurite branching, albeit with no differences in corresponding synaptic puncta formation. When rat pups were injected subcutaneously with DEX 25 µg/kg on postnatal day 7 and again on postnatal day 8, we discovered that this agent did not affect hippocampal-dependent memory in freely behaving animals. Our data demonstrates, for the first time, the non-neurotoxic nature of DEX both in vitro and in vivo in an animal model providing support for its utility as a safer anesthetic agent. Moreover, this study provides the first direct evidence that although DEX is growth permissive, causes mitochondrial fusion and reduces oxygen reactive species production, it does not affect the total number of synaptic connections between the cortical neurons in vitro.

25 February 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FIFahad Iqbal
Fahad Iqbal
MPMarcus Pehar
Marcus Pehar
ATAndrew J. Thompson
Andrew J. Thompson
UAUrva Azeem
Urva Azeem
KJKiana Jahanbakhsh
Kiana Jahanbakhsh
Naweed SyedNaweed Syed
Naweed Syed
Anesthetics are deemed necessary for all major surgical procedures. However, they have also been found to exert neurotoxic effects when tested on various experimental models, but the underlying mechanisms remain unknown. Earlier studies have implicated mitochondrial fragmentation as a potential target of anesthetic-induced toxicity, although clinical strategies to protect their structure and function remain sparse. Here, we sought to determine if preserving mitochondrial networks with a non-toxic, short-life synthetic peptide—P110, would protect cortical neurons against both inhalational and intravenous anesthetic-induced neurotoxicity. This study provides the first direct and comparative account of three key anesthetics (desflurane, propofol, and ketamine) when used under identical conditions, and demonstrates their impact on neonatal, rat cortical neuronal viability, neurite outgrowth and synaptic assembly. Furthermore, we discovered that inhibiting Fis1-mediated mitochondrial fission reverses anesthetic-induced aberrations in an agent-specific manner. This study underscores the importance of designing mitigation strategies invoking mitochondria-mediated protection from anesthetic-induced toxicity in both animals and humans.

24 February 2026 in Virtual Reality
Verified
Journal Article
Open access
PDF file
ACAlberto Casas-Ortiz
Alberto Casas-Ortiz
Nerea Jimenez-TellezNerea Jimenez-Tellez
Nerea Jimenez-Tellez
MPMiguel Portaz
Miguel Portaz
Olga C. SantosOlga C. Santos
Olga C. Santos
Developing Intelligent Systems for Psychomotor Learning (ISPLs) is a complex challenge, particularly when integrating psychomotor, cognitive, and affective learning domains with advanced technologies like Artificial Intelligence (AI) and Extended Reality (XR) for personalization and immersivity. Despite growing interest, there is no comprehensive framework to create such systems. This paper introduces PsyLearn , a comprehensive framework that addresses this gap, developed through combining and analyzing tools, methods, and frameworks identified through a systematic review, and insights from the creation of the Kenpo Learning Simulator (KLS), a VR-based ISPL that teaches martial arts defensive movements using AI-based pose estimation, rules, real-time feedback, and a virtual agent. The framework integrates emerging technologies while addressing ethics, feasibility, and system evaluation, offering a modular and scalable approach to ISPL development. Key contributions include: (1) PsyLearn , a comprehensive framework for ISPL development; (2) KLS, a proof-of-concept VR-based ISPL for martial arts training; and (3) a systematic review identifying gaps and providing tools for ISPL development. By bridging theory and practice, PsyLearn advances ISPL development and lays the groundwork for integrating AI, XR, and emerging technologies into educational systems. Preliminary evaluations of KLS demonstrate its potential to improve motor skills, while also highlighting areas for refinement. This work emphasizes the importance of interdisciplinary collaboration and iterative design in creating effective, ethical, and scalable learning solutions that address the complexities of psychomotor, cognitive, and affective learning domains.